8-K
filed June 4, 2026, 4:07 PM ET
ticker VMD
CIK 0001729149
other material
confidence high
sentiment neutral
materiality 0.55
Viemed Healthcare shareholders approve LTIP amendment, increase share reserve to 7.70M
VIEMED HEALTHCARE, INC.
- LTIP share reserve increased to 7,696,717 shares, including up to 1M incentive stock options.
- All seven directors elected; Sabrina Heltz received 79.76% support (20.24% withheld).
- Say-on-pay advisory vote passed with 93.21% approval.
- Ernst & Young LLP ratified as independent auditor for FY 2026.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VIEMED HEALTHCARE, INC. shareholders approved Ratification of Second Amendment to the 2024 LTIP.
- Proposal
- equity plan
- Outcome
- passed
Exact text from the filing
Shareholders approved an ordinary resolution to ratify, confirm, and approve the Second Amendment to the 2024 LTIP.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VIEMED HEALTHCARE, INC. shareholders approved Election of seven director nominees.
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
Shareholders elected each of the seven director nominees to serve until the next annual meeting of shareholders or until their successors are duly elected or appointed.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VIEMED HEALTHCARE, INC. shareholders approved Advisory vote on executive compensation.
- Proposal
- say on pay
- Outcome
- passed
Exact text from the filing
Shareholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers (the “say-on-pay” vote).
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
VIEMED HEALTHCARE, INC. shareholders approved Appointment of Ernst & Young LLP as independent auditors at the 2026-12-31 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-12-31
Exact text from the filing
Shareholders approved the appointment of Ernst & Young LLP as the Company’s independent auditors for the fiscal year ending December 31, 2026, and authorized the Company's Board of Directors to fix their remuneration.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.